Merck Targets Experts In Next Fosamax Bellwether

Law360, New York (October 12, 2010, 6:45 PM EDT) -- Fresh off a victory in another case over Fosamax, lawyers for plaintiff Judith Graves on Tuesday battled Merck & Co. Inc.'s efforts to prevent her physicians from testifying at a possible trial that the osteoporosis drug caused a bone-rotting condition in her jaw.

Attorney Timothy M. O’Brien, of Levin Papantonio Thomas Mitchell Echsner Rafferty & Proctor PA, who also handled the winning case for plaintiff Shirley Boles, told a judge in the U.S. District Court for the Southern District of New York that the doctors’ testimony...
To view the full article, register now.